Bio Planet S.A.

As of March 31, 2026, Bio Planet S.A. carries a market capitalization of 88.50M, placing it among publicly traded companies globally. Its enterprise value stands at 88.34M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Bio Planet S.A. has 3.00M shares outstanding.

As of March 31, 2026, Bio Planet S.A. trades at a trailing price-to-earnings ratio of 11.39. The price-to-sales ratio is 0.27, and the price-to-book ratio stands at 2.59.

As of March 31, 2026, Bio Planet S.A. trades at an EV/EBITDA multiple of 6.21 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.27 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 7.95 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 88.34M versus a market cap of 88.50M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Bio Planet S.A. maintains a current ratio of 1.02, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended March 31, 2026, Bio Planet S.A. posted a return on equity (ROE) of 26.00, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 19.05 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.74, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 19.89, useful for judging operating efficiency across full business cycles. Inventory turnover of 8.40 indicates how many times Bio Planet S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Bio Planet S.A. recorded 1.85M in income tax expense. That works out to an effective tax rate of 19.21, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 9.63M, leaving 7.78M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Bio Planet S.A.'s stock has declined approximately 2.27% over the past 52 weeks. The 50-day moving average sits at 24.87, while the 200-day moving average is 28.83.

Over the twelve months ended March 31, 2026, Bio Planet S.A. generated 328.95M in revenue and converted that into 7.78M in net income, yielding earnings per share of 2.59. EBITDA reached 14.22M, while operating income came in at 12.68M.

These figures are as of March 31, 2026. Total book value stands at 34.18M, with working capital of 1.43M providing operational flexibility.

Bio Planet S.A. produced -432,000.00 in operating cash flow over the twelve months ended March 31, 2026. After subtracting -1.77M in capital expenditures, free cash flow totaled -2.20M - equivalent to -0.73 per share.

Over the twelve months ended March 31, 2026, Bio Planet S.A. posted a gross margin of 29.75, reflecting its pricing power and cost economics. The operating margin of 3.86 and net profit margin of 2.36 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Bio Planet S.A. paid dividends of 0.10 per share. The dividend payout ratio of 3.86 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -2.48: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1.46, meaning Bio Planet S.A. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of March 31, 2026, Bio Planet S.A. has an Altman Z-Score of 3.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.